Tobie D. Lee

1.8k total citations · 1 hit paper
11 papers, 880 citations indexed

About

Tobie D. Lee is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Tobie D. Lee has authored 11 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Tobie D. Lee's work include Drug Transport and Resistance Mechanisms (2 papers), CRISPR and Genetic Engineering (2 papers) and Ubiquitin and proteasome pathways (2 papers). Tobie D. Lee is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), CRISPR and Genetic Engineering (2 papers) and Ubiquitin and proteasome pathways (2 papers). Tobie D. Lee collaborates with scholars based in United States, India and China. Tobie D. Lee's co-authors include Bang Shen, L. David Sibley, Kevin M. Brown, Matthew D. Hall, Michael M. Gottesman, James P. Madigan, Ian S. Goldlust, James D. Hoeschele, John R. Lloyd and Katherine A. Telma and has published in prestigious journals such as Cell, Cancer Research and Scientific Reports.

In The Last Decade

Tobie D. Lee

11 papers receiving 874 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii Using CRISPR/CAS9

2014 367 citations Bang Shen, Kevin M. Brown et al. mBio profile →

Peers

Countries citing papers authored by Tobie D. Lee

Since Specialization

Citations

This map shows the geographic impact of Tobie D. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobie D. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobie D. Lee more than expected).

Fields of papers citing papers by Tobie D. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobie D. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobie D. Lee. The network helps show where Tobie D. Lee may publish in the future.

Co-authorship network of co-authors of Tobie D. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Tobie D. Lee. A scholar is included among the top collaborators of Tobie D. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobie D. Lee. Tobie D. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions 2024 ·Science Advances ·(unknown), Kelli M. Wilson, (unknown), (unknown), (unknown), Tobie D. Lee, (unknown), Rebecca M. Richards, Matthew D. Hall, Jason R. Cantor	5
2	Pan-cancer proteogenomics expands the landscape of therapeutic targets 2024 ·Cell ·Sara R. Savage, Xinpei Yi, Jonathan T. Lei, Bo Wen, Hongwei Zhao, Yuxing Liao, Eric J. Jaehnig, (unknown), Paul Shafer, Tobie D. Lee, (unknown), Yongchao Dou, Zhiao Shi, Daming Gao, Valentina Hoyos, Qiang Gao, Bing Zhang	33
3	Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter 2021 ·Scientific Reports ·Robert W. Robey, (unknown), (unknown), Lyn M. Huff, Sabrina Lusvarghi, (unknown), (unknown), Andrew Warner, Donna Butcher, (unknown), Elijah F. Edmondson, Tobie D. Lee, Jacob S. Roth, Olivia W. Lee, Min Shen, Kandice Tanner, Matthew D. Hall, Suresh V. Ambudkar, Michael M. Gottesman	22
4	Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen–Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based Design 2021 ·ACS Chemical Biology ·Scott J. Eron, Hongwei Huang, Roman V. Agafonov, Mark E. Fitzgerald, Joe Patel, (unknown), Tobie D. Lee, (unknown), (unknown), Christopher G. Nasveschuk, Andrew J. Phillips, Stewart L. Fisher, Andrew C. Good	32
5	Keeping It Clean: The Cell Culture Quality Control Experience at the National Center for Advancing Translational Sciences 2020 ·SLAS DISCOVERY ·Jacob S. Roth, Tobie D. Lee, Dorian M. Cheff, Maya L. Gosztyla, (unknown), Carina Danchik, Sam Michael, Anton Simeonov, Carleen Klumpp‐Thomas, Kelli M. Wilson, Matthew D. Hall	6
6	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein 2019 ·Molecular Pharmacology ·Tobie D. Lee, Olivia W. Lee, Kyle R. Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, (unknown), Carleen Klumpp‐Thomas, Robert W. Robey, Suresh V. Ambudkar, Min Shen, Michael M. Gottesman, Matthew D. Hall	22
7	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening 2019 ·SLAS DISCOVERY ·Olivia W. Lee, (unknown), (unknown), Dorian M. Cheff, Tobie D. Lee, Kelli M. Wilson, Joseph M. Johnson, Jameson Travers, John Braisted, Rajarshi Guha, Carleen Klumpp‐Thomas, Min Shen, Matthew D. Hall	12
8	Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors 2018 ·Bioorganic & Medicinal Chemistry ·Jason M. Rohde, Kyle R. Brimacombe, Li Liu, Michael E. Pacold, Adam Yasgar, Dorian M. Cheff, Tobie D. Lee, Ganesha Rai, Bolormaa Baljinnyam, Zhuyin Li, Anton Simeonov, Matthew D. Hall, Min Shen, David M. Sabatini, Matthew B. Boxer	35
9	Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes 2014 ·Cancer Research ·Matthew D. Hall, Katherine A. Telma, (unknown), Tobie D. Lee, James P. Madigan, John R. Lloyd, Ian S. Goldlust, James D. Hoeschele, Michael M. Gottesman	293
10	Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii Using CRISPR/CAS9 breakdown → 2014 ·mBio ·Bang Shen, Kevin M. Brown, Tobie D. Lee, L. David Sibley	367
11	Functional Analysis of Rhomboid Proteases during Toxoplasma Invasion 2014 ·mBio ·Bang Shen, Jeffrey S. Buguliskis, Tobie D. Lee, L. David Sibley	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact